1217709-85-7
1217709-85-7
Chemical Structure
Repaglinide-d5
Synonym(s): AG-EE 623ZW d5
- CAS No.: 1217709-85-7
- Formula:C27H31D5N2O4
- Molecular Weight:457.62
IUPAC Name: (S)-2-(ethoxy-d5)-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
InChIKey: FAEKWTJYAYMJKF-NTSVIFQKSA-N
SMILES: O=C(O)C1=CC=C(CC(N[C@H](C2=CC=CC=C2N3CCCCC3)CC(C)C)=O)C=C1OC([2H])([2H])C([2H])([2H])[2H]
Biological Activity: Repaglinide-d5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Repaglinide-d5 | 98.67% | Repaglinide-d5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Repaglinide (Standard) | 99.96% | Repaglinide (Standard) is the analytical standard of Repaglinide. This product is intended for research and analytical applications. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Repaglinide | 99.89% | Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
